In Vivo CRO Global Market Analysis, Growth, Opportunities, Top Key Players and Forecast to 2025
This report focuses on the global In Vivo CRO status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vivo CRO development in United States, Europe and China.
In 2017, the global In Vivo CRO market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
The key players covered in this study
Quintiles
Charles River Laboratories
ICON Plc
Covance Inc.
Parexel International
Pharmaceutical Product Development, LLC (PPD)
Theorem Clinical research
inVentiv Health
WuXi AppTec, Inc.
American Preclinical Services, LLC.
Evotec (US), Inc.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3369442-global-in-vivo-cro-market-size-status-and-forecast-2018-2025
Market segment by Type, the product can be split into
Rodent
Non-Rodent
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Complete Report Details @ https://www.wiseguyreports.com/reports/3369442-global-in-vivo-cro-market-size-status-and-forecast-2018-2025
Table Of Contents:
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global In Vivo CRO Market Size Growth Rate by Type (2013-2025)
1.4.2 Rodent
1.4.3 Non-Rodent
1.5 Market by Application
1.5.1 Global In Vivo CRO Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 In Vivo CRO Market Size
2.2 In Vivo CRO Growth Trends by Regions
2.2.1 In Vivo CRO Market Size by Regions (2013-2025)
2.2.2 In Vivo CRO Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
….
12 International Players Profiles
12.1 Quintiles
12.1.1 Quintiles Company Details
12.1.2 Company Description and Business Overview
12.1.3 In Vivo CRO Introduction
12.1.4 Quintiles Revenue in In Vivo CRO Business (2013-2018)
12.1.5 Quintiles Recent Development
12.2 Charles River Laboratories
12.2.1 Charles River Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 In Vivo CRO Introduction
12.2.4 Charles River Laboratories Revenue in In Vivo CRO Business (2013-2018)
12.2.5 Charles River Laboratories Recent Development
12.3 ICON Plc
12.3.1 ICON Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 In Vivo CRO Introduction
12.3.4 ICON Plc Revenue in In Vivo CRO Business (2013-2018)
12.3.5 ICON Plc Recent Development
12.4 Covance Inc.
12.4.1 Covance Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 In Vivo CRO Introduction
12.4.4 Covance Inc. Revenue in In Vivo CRO Business (2013-2018)
12.4.5 Covance Inc. Recent Development
12.5 Parexel International
12.5.1 Parexel International Company Details
12.5.2 Company Description and Business Overview
12.5.3 In Vivo CRO Introduction
12.5.4 Parexel International Revenue in In Vivo CRO Business (2013-2018)
12.5.5 Parexel International Recent Development
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Friday October 12 2018, 7:56 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
